Literature DB >> 2183296

Retroviral-mediated gene transfer.

J R McLachlin1, K Cornetta, M A Eglitis, W F Anderson.   

Abstract

Mesh:

Year:  1990        PMID: 2183296     DOI: 10.1016/s0079-6603(08)60709-6

Source DB:  PubMed          Journal:  Prog Nucleic Acid Res Mol Biol        ISSN: 0079-6603


× No keyword cloud information.
  17 in total

1.  Unusually high frequency of reconstitution of long terminal repeats in U3-minus retrovirus vectors by DNA recombination or gene conversion.

Authors:  P Olson; H M Temin; R Dornburg
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

Review 2.  Prospects for homologous recombination in human gene therapy.

Authors:  M A Vega
Journal:  Hum Genet       Date:  1991-07       Impact factor: 4.132

3.  Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination.

Authors:  J Bergemann; K Kühlcke; B Fehse; I Ratz; W Ostertag; H Lother
Journal:  Nucleic Acids Res       Date:  1995-11-11       Impact factor: 16.971

Review 4.  Development of retroviral vectors as safe, targeted gene delivery systems.

Authors:  W H Günzburg; B Salmons
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

5.  Adenovirus mediated-gene transfer into cardiomyocytes.

Authors:  L A Kirshenbaum
Journal:  Mol Cell Biochem       Date:  1997-07       Impact factor: 3.396

Review 6.  The Gordon Wilson Lecture. In vivo gene therapy: a strategy to use human genes as therapeutics.

Authors:  R G Crystal
Journal:  Trans Am Clin Climatol Assoc       Date:  1995

7.  Characterization of replication-competent retroviruses from nonhuman primates with virus-induced T-cell lymphomas and observations regarding the mechanism of oncogenesis.

Authors:  E F Vanin; M Kaloss; C Broscius; A W Nienhuis
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

Review 8.  Human cancer and gene therapy.

Authors:  G Schmidt-Wolf; I G Schmidt-Wolf
Journal:  Ann Hematol       Date:  1994-12       Impact factor: 3.673

9.  Recombinant retrovirus vectors for the expression of MHC class II heterodimers.

Authors:  H Shimada; R C Alexander; S Germana; D H Sachs; C LeGuern
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

10.  Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.

Authors:  R Bergan; Y Connell; B Fahmy; L Neckers
Journal:  Nucleic Acids Res       Date:  1993-07-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.